Enhanced antibody production in mice to the malaria antigen AMA 1 by CPG 7909 requires physical association of CpG and antigen

Gregory E. D. Mullen, Joan A. Aebig, Gelu Dobrescu, Kelly Rausch, Lynn Lambert, Carole A. Long, Aaron P. Miles, Allan Saul

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

CpG oligodeoxynucleotides are potent immunostimulants. In this study, CPG 7909 was formulated with the recombinant Plasmodium falciparum protein AMA1-C1 adsorbed to Alhydrogel (aluminum hydroxide) and used to immunize mice. Mice receiving free CPG 7909 in a separate same site injection to the AMA1-C1/Alhydrogel had the same antibody responses as mice receiving AMA1 -C1/Alhydrogel alone. For mice immunized with CPG 7909 bound to the AMA1-C1/Alhydrogel formulation, there was a bell shaped CPG 7909 dose-response curve with the highest antibody response co-incident with the concentration of CPG 7909 that saturated binding to the Alhydrogel. At a higher CPG 7909 dose where 74% was unbound, there was no enhancement of response over AMA1-C1/Alhydrogel alone. Our results suggest that the adjuvant effects of CpGs are optimal when adsorbed to Alhydrogel and highlight the need for careful characterization of the vaccine formulation. (c) 2007 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)5343-5347
Number of pages5
JournalVaccine
Volume25
Issue number29
DOIs
Publication statusPublished - 20 Jul 2007

Fingerprint

Dive into the research topics of 'Enhanced antibody production in mice to the malaria antigen AMA 1 by CPG 7909 requires physical association of CpG and antigen'. Together they form a unique fingerprint.

Cite this